![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mayer R.J. Marshall L.A.
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 333-344
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potential therapeutic uses of phospholipase A2 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phospholipase A2 Inhibitors as Potential Anti-Inflammatory Agents
Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)